These findings align with the results reported by Lee et al. [40], who similarly concluded that individuals with elevated ANGPTL8 levels exhibited a risk of developing MetS and diabetes that was more than three times higher than those with lower levels. This evidence concerns the gene ANGPTL8 and metabolic syndrome.